Vaccine preparation

Development and characterization of Rift Valley fever virus-like particles

Y. T. Li, Wang, C. L., Zheng, X. X., Wang, H. L., Zhao, Y. K., Gai, W. W., Jin, H. L., Gao, Y. W., Li, N., Yang, S. T., Xia, X. Z., Li, Y. T., Wang, C. L., Zheng, X. X., Wang, H. L., Zhao, Y. K., Gai, W. W., Jin, H. L., Gao, Y. W., Li, N., Yang, S. T., Xia, X. Z., Li, Y. T., Wang, C. L., Zheng, X. X., Wang, H. L., Zhao, Y. K., Gai, W. W., Jin, H. L., Gao, Y. W., Li, N., Yang, S. T., and Xia, X. Z., Development and characterization of Rift Valley fever virus-like particles, vol. 15, p. -, 2016.

Rift Valley fever (RVF) is an acute, febrile zoonotic disease that is caused by the RVF virus (RVFV) and spread by arthropod vectors. RVF is currently prevalent in Africa and the Arabian Peninsula, and causes substantial economic losses. Furthermore, this disease poses a serious threat to animal and human health in regions worldwide, making it a serious public health concern. However, RVFV vaccines for human use are still unavailable, and hence there is an urgent need for novel efficient vaccines against RVFV.

Subscribe to Vaccine preparation